Last Posted: Apr 16, 2020
- Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing.
Vlessis Katherine et al. JNCI cancer spectrum 2020 Feb 4(1) pkz095 - Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170 - Population-based genetic testing for Women's cancer prevention.
Evans Olivia et al. Best practice & research. Clinical obstetrics & gynaecology 2020 Mar - I Have a BRCA1 Gene Mutation: The Extra Stress of COVID-19 Takes a Toll
N McCoy, blog April 2, 2020 - Breast Conserving Surgery for BRCA Mutation Carriers-A Systematic Review.
Co Michael et al. Clinical breast cancer 2019 Aug - The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
Laitman Yael et al. Human mutation 2019 40(11) e1-e23 - Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer.
Emborgo Trisha S et al. JNCI cancer spectrum 2020 Apr 4(2) pkaa002 - BRCA1 / BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
Lee Anbok et al. Annals of laboratory medicine 2020 Mar 40(2) 114-121 - Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P et al. Molecular biology reports 2020 Mar - Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care.
Hong Linda et al. Gynecologic and obstetric investigation 2020 Mar 1-8
.png)
No hay comentarios:
Publicar un comentario